Tag archive for ‘Yaron Daniely’
Gali Weinreb On Sunday, January 11th, 2015

ADHD treatment co Alcobra raises $26 million on Nasdaq

– The company plans a second Phase III trial in the US for ADHD, drawing lessons from the previous Phase III trial.   Alcobra Pharmaceuticals Ltd. (Nasdaq: ADHD), which is developing a drug for More...

Wordpress site Developed by Fixing WordPress Problems